De Larme Wealth Management, Inc. Veracyte, Inc. Transaction History
De Larme Wealth Management, Inc.
- $141 Billion
- Q4 2025
A detailed history of De Larme Wealth Management, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, De Larme Wealth Management, Inc. holds 6,000 shares of VCYT stock, worth $236,100. This represents 0.18% of its overall portfolio holdings.
Number of Shares
6,000Holding current value
$236,100% of portfolio
0.18%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
329Shares Held
78.4MCall Options Held
94.6KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA8.5MShares$335 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$307 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI7.37MShares$290 Million0.39% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.47MShares$176 Million1.08% of portfolio
-
State Street Corp Boston, MA4.2MShares$165 Million0.01% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.82B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...